BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11818260)

  • 21. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World.
    Suzuki J; Nakai N; Kondo N; Tsuji H; Inagaki R; Furukawa S; Iwata M; Nishida S; Ito Y
    Cerebrovasc Dis; 2018; 46(3-4):184-192. PubMed ID: 30384371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stroke busters. New treatments in the fight against 'brain attacks'.
    Schrof JM
    US News World Rep; 1999 Mar; 126(10):62-4, 68. PubMed ID: 10346396
    [No Abstract]   [Full Text] [Related]  

  • 23. Treating the elderly stroke patient: complications, controversies, and best care metrics.
    Heitsch LE; Panagos PD
    Clin Geriatr Med; 2013 Feb; 29(1):231-55. PubMed ID: 23177609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute ischemic stroke update.
    Baldwin K; Orr S; Briand M; Piazza C; Veydt A; McCoy S
    Pharmacotherapy; 2010 May; 30(5):493-514. PubMed ID: 20412000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which patients with suspected myocardial ischemia and left bundle-branch block should receive thrombolytic agents?
    Gallagher EJ
    Ann Emerg Med; 2001 May; 37(5):439-44. PubMed ID: 11326178
    [No Abstract]   [Full Text] [Related]  

  • 26. Misdiagnosis of stroke in tissue plasminogen activator-treated patients: characteristics and outcomes.
    Scott PA; Silbergleit R
    Ann Emerg Med; 2003 Nov; 42(5):611-8. PubMed ID: 14581912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Controversy: the essence of medical debate.
    Donnan GA; Davis SM
    Stroke; 2003 Feb; 34(2):372-3. PubMed ID: 12574541
    [No Abstract]   [Full Text] [Related]  

  • 28. Aggregation of marginal gains in the care of acute stroke.
    O'Brien A; Guyler P
    Br J Hosp Med (Lond); 2009 Mar; 70(3):154-6. PubMed ID: 19274005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The changing face of stroke. Medical management revolution.
    Cadilhac D
    Aust Nurs J; 1998 Jun; 5(11):18-21. PubMed ID: 10639958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prehospital stroke care: potential, pitfalls, and future.
    Mazighi M; Derex L; Amarenco P
    Curr Opin Neurol; 2010 Feb; 23(1):31-5. PubMed ID: 19926988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EMS mythology. EMS myth #2. Thombolytic therapy is the standard of care for acute ischemic stroke.
    Bledsoe BE
    Emerg Med Serv; 2003 Apr; 32(4):63-5. PubMed ID: 12705219
    [No Abstract]   [Full Text] [Related]  

  • 32. Endovascular treatment for acute ischemic stroke: experience in South Australia.
    Rudaks LI; Ahangar I; Dodd L; Milton AG; Hamilton-Bruce MA; Jannes J; Koblar SA
    Int J Stroke; 2015 Aug; 10(6):E64-5. PubMed ID: 26202716
    [No Abstract]   [Full Text] [Related]  

  • 33. The 'golden hour' treatment of acute ischemic stroke.
    Iqbal A
    Med Health R I; 2011 Dec; 94(12):378-9. PubMed ID: 22409132
    [No Abstract]   [Full Text] [Related]  

  • 34. Cutting Edge Acute Ischemic Stroke Management.
    Urdaneta AE; Bhalla P
    Emerg Med Clin North Am; 2019 Aug; 37(3):365-379. PubMed ID: 31262409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stroke thrombolysis: Barriers to implementation.
    Carter-Jones CR
    Int Emerg Nurs; 2011 Jan; 19(1):53-7. PubMed ID: 21193168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four evolving strategies in the emergent treatment of acute ischemic stroke.
    Thurman RJ; Jauch EC; Panagos PD; Reynolds MR; Mocco J
    Emerg Med Pract; 2012 Jul; 14(7):1-26; quiz 26-7. PubMed ID: 22872954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Policy: Use of Intravenous Tissue Plasminogen Activator for the Management of Acute Ischemic Stroke in the Emergency Department.
    ; Brown MD; Burton JH; Nazarian DJ; Promes SB
    Ann Emerg Med; 2015 Sep; 66(3):322-333.e31. PubMed ID: 26304253
    [No Abstract]   [Full Text] [Related]  

  • 38. New advances in the management of acute coronary syndromes: 1. Matching treatment to risk.
    Fitchett D; Goodman S; Langer A
    CMAJ; 2001 May; 164(9):1309-16. PubMed ID: 11341143
    [No Abstract]   [Full Text] [Related]  

  • 39. Management of acute stroke.
    Zweifler RM
    South Med J; 2003 Apr; 96(4):380-5. PubMed ID: 12916557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stroke therapy in patients considering prothrombin time and international normalized ratio.
    Albright K; Stemer A; Tafreshi G; Hemmen T
    Stroke; 2010 Jun; 41(6):e450; author reply e451. PubMed ID: 20448205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.